The ECLA PHRI COLCOVID Trial. Effects of Colchicine on Moderate/High-risk Hospitalized COVID-19 Patients.
Status:
Completed
Trial end date:
2021-04-26
Target enrollment:
Participant gender:
Summary
The ECLA PHRI COLCOVID Trial is a simple, pragmatic randomized open controlled trial to test
the effects of colchicine on moderate/high-risk hospitalized COVID-19 patients with the aim
of reducing mortality and/or new requirement for mechanical ventilation.